The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
From Fibrosis to Sclerosis
Open accessAbstract
Progression of diabetic nephropathy to end-stage kidney disease is mediated by a host of processes, but none is as important as the gradual, inexorable scarring of the renal glomerulus, known as glomerulosclerosis. Hence, a host of studies over the decades have attempted to elucidate the molecular mechanisms that lead to this chronic sclerosing condition so that effective therapies and preventative strategies can be developed. Over the past several years, the general understanding of the pathogenic factors that lead to this important feature of diabetic nephropathy has improved considerably. Glomerulosclerosis in diabetic nephropathy is caused by accumulation of extracellular matrix (ECM) proteins in the mesangial interstitial space, resulting in fibrosis manifested by either diffuse or nodular changes (1). The most common matrix proteins detected are collagen types I, III, and IV and fibronectin (2). These accumulate both due to increased synthesis by mesangial cells and reduced degradation by mesangial matrix metalloproteinases (3). Over 20 years ago, Mauer et al. (4) established the clear link between mesangial matrix expansion and progression of diabetic kidney disease by demonstrating that measures of mesangial expansion strongly predicted the clinical manifestations of diabetic nephropathy. Since then, the critical charge to investigators has been to elucidate the mechanisms that promote glomerulosclerosis in diabetic nephropathy. In this brief perspective, we will review pathogenic processes that appear to be critical in the development of diabetic glomerulosclerosis, emphasizing newer findings and insights. During the 1990s, a general consensus emerged about major signaling mechanisms involved in stimulating mesangial cell synthesis of ECM proteins (Fig. 1). In this consensus view, high extracellular glucose induces an increase in glucose uptake via increased expression of the facilitative glucose transporter GLUT1 (5,6). The resultant enhancement in glucose metabolic flux leads to activation of a number of metabolic pathways that result in increased advanced …
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eremina, V., Sood, M., Haigh, J., Nagy, A., Lajoie, G., Ferrara, N., Gerber, H.-P., Kikkawa, Y., Miner, J. H., & Quaggin, S. E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17423 · Cited by 1,313
Structural-functional relationships in diabetic nephropathy.
Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M., & Goetz, F. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111523 · Cited by 1,209
Podocyte loss and progressive glomerular injury in type II diabetes.
Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., & Meyer, T. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119163 · Cited by 1,088
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy
Makita, Z., Radoff, S., Rayfield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., & Vlassara, H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109193251202 · Cited by 918
Mouse Models of Diabetic Nephropathy
Brosius, F. C., Alpers, C. E., Bottinger, E. P., Breyer, M. D., Coffman, T. M., Gurley, S. B., Harris, R. C., Kakoki, M., Kretzler, M., Leiter, E. H., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009070721 · Cited by 895
Self-citationYamamoto, T., Nakamura, T., Noble, N. A., Ruoslahti, E., & Border, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1814 · Cited by 830
Wharram, B. L., Goyal, M., Wiggins, J. E., Sanden, S. K., Hussain, S., Filipiak, W. E., Saunders, T. L., Dysko, R. C., Kohno, K., Holzman, L. B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010055 · Cited by 737
Kato, M., Zhang, J., Wang, M., Lanting, L., Yuan, H., Rossi, J. J., & Natarajan, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611192104 · Cited by 699
Extracellular Matrix Metabolism in Diabetic Nephropathy
Mason, R. M., & Wahab, N. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065640.77499.d7 · Cited by 655
Ziyadeh, F. N., Sharma, K., Ericksen, M., & Wolf, G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117004 · Cited by 597
Pathogenetic Mechanisms of Diabetic Nephropathy
Schena, F. P., & Gesualdo, L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110970 · Cited by 589
Chow, F., Ozols, E., Nikolic-Paterson, D. J., Atkins, R. C., & Tesch, G. H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00367.x · Cited by 551
Mouse Models of Diabetic Nephropathy
Breyer, M. D., Bo[Combining Diaeresis]ttinger, E., Brosius, F. C., Coffman, T. M., Harris, R. C., Heilig, C. W., & Sharma, K. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080648 · Cited by 467
Self-citationMeyer, T. W., Bennett, P. H., & Nelson, R. G. (1999) · Diabetologia · doi:10.1007/s001250051447 · Cited by 445
MicroRNA—implications for cancer
Sassen, S., Miska, E. A., & Caldas, C. (2008) · Virchows Archiv · doi:10.1007/s00428-007-0532-2 · Cited by 441
Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., Rollin, B. J., & Tesch, G. H. (2006) · Kidney International · doi:10.1038/sj.ki.5000014 · Cited by 440
Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersole de Strihou, C., Monnier, V. M., Witztum, J. L., & Kurokawa, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119853 · Cited by 433
Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy
Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., Nitsche, A., Kiss, E., Bleich, M., Gröne, H.-J., et al. (2006) · Diabetes · doi:10.2337/db06-0477 · Cited by 419
Self-citationIsermann, B., Vinnikov, I. A., Madhusudhan, T., Herzog, S., Kashif, M., Blautzik, J., Corat, M. A. F., Zeier, M., Blessing, E., Oh, J., et al. (2007) · Nature Medicine · doi:10.1038/nm1667 · Cited by 385
Diabetic Endothelial Nitric Oxide Synthase Knockout Mice Develop Advanced Diabetic Nephropathy
Nakagawa, T., Sato, W., Glushakova, O., Heinig, M., Clarke, T., Campbell-Thompson, M., Yuzawa, Y., Atkinson, M. A., Johnson, R. J., & Croker, B. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050459 · Cited by 370
Marre, M., Bernadet, P., Gallois, Y., Savagner, F., Guyene, T.-T., Hallab, M., Cambien, F., Passa, P., & Alhenc-Gelas, F. (1994) · Diabetes · doi:10.2337/diab.43.3.384 · Cited by 366
Endothelial Nitric Oxide Synthase Deficiency Produces Accelerated Nephropathy in Diabetic Mice
Zhao, H. J., Wang, S., Cheng, H., Zhang, M.-Z., Takahashi, T., Fogo, A. B., Breyer, M. D., & Harris, R. C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070798 · Cited by 359
Sun, L., Halaihel, N., Zhang, W., Rogers, T., & Levi, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110650200 · Cited by 333
Proctor, G., Jiang, T., Iwahashi, M., Wang, Z., Li, J., & Levi, M. (2006) · Diabetes · doi:10.2337/db05-0603 · Cited by 303
Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
Dalla Vestra, M., Mussap, M., Gallina, P., Bruseghin, M., Cernigoi, A. M., Saller, A., Plebani, M., & Fioretto, P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110961 · Cited by 303
Okada, S., Shikata, K., Matsuda, M., Ogawa, D., Usui, H., Kido, Y., Nagase, R., Wada, J., Shikata, Y., & Makino, H. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2586 · Cited by 298
The Pathogenesis of Chronic Renal Failure in Diabetic Nephropathy
Bohle, A., Wehrmann, M., Bogenschütz, O., Batz, C., Müller, G. A., & Müller, G. A. (1991) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80780-6 · Cited by 285
Derubertis, F. R., & Craven, P. A. (1994) · Diabetes · doi:10.2337/diabetes.43.1.1 · Cited by 275
Toyoda, M., Najafian, B., Kim, Y., Caramori, M. L., & Mauer, M. (2007) · Diabetes · doi:10.2337/db07-0019 · Cited by 257
Chen, S., Jim, B., & Ziyadeh, F. N. (2003) · Seminars in Nephrology · doi:10.1053/s0270-9295(03)00132-3 · Cited by 256
Skolnik, E. Y., Yang, Z., Makita, Z., Radoff, S., Kirstein, M., & Vlassara, H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.931 · Cited by 244
Interstitial Vascular Rarefaction and Reduced VEGF-A Expression in Human Diabetic Nephropathy
Lindenmeyer, M. T., Kretzler, M., Boucherot, A., Berra, S., Yasuda, Y., Henger, A., Eichinger, F., Gaiser, S., Schmid, H., Rastaldi, M. P., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121304 · Cited by 241
Self-citationFarnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy
Jiang, T., Wang, X. X., Scherzer, P., Wilson, P., Tallman, J., Takahashi, H., Li, J., Iwahashi, M., Sutherland, E., Arend, L., et al. (2007) · Diabetes · doi:10.2337/db06-1642 · Cited by 236
Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update
Alsaad, K. O., & Herzenberg, A. M. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.035592 · Cited by 235
Navarro, J. F., Milena, F. J., Mora, C., León, C., & García, J. (2006) · American Journal of Nephrology · doi:10.1159/000098004 · Cited by 220
Role of the JAK/STAT signaling pathway in diabetic nephropathy
Marrero, M. B., Banes-Berceli, A. K., Stern, D. M., & Eaton, D. C. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00181.2005 · Cited by 219
Zanchi, A., Moczulski, D. K., Hanna, L. S., Wantman, M., Warram, J. H., & Krolewski, A. S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00860.x · Cited by 196
Cheng, H.-F., Wang, C. J., Moeckel, G. W., Zhang, M.-Z., Mckanna, J. A., & Harris, R. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00520.x · Cited by 193
Doria, A., Warram, J. H., & Krolewski, A. S. (1994) · Diabetes · doi:10.2337/diab.43.5.690 · Cited by 191
Chander, P. N., Gealekman, O., Brodsky, S. V., Elitok, S., Tojo, A., Crabtree, M., Gross, S. S., & Goligorsky, M. S. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135971.88164.2c · Cited by 171
Role of nitric oxide in diabetic nephropathy
Prabhakar, S. S. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2004.04.005 · Cited by 167
Nephron Number and Renal Risk in Hypertension and Diabetes
Groβ, M.-L., Amann, K., & Ritz, E. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110967 · Cited by 160
Huang, W., Gallois, Y., Bouby, N., Bruneval, P., Heudes, D., Belair, M., Krege, J. H., Meneton, P., Marre, M., Smithies, O., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231476798 · Cited by 151
Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor
Kakoki, M., Takahashi, N., Jennette, J. C., & Smithies, O. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405449101 · Cited by 142
The Renin-Angiotensin System and Diabetic Nephropathy
Gurley, S. B., & Coffman, T. M. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.009 · Cited by 137
Adenosine A2Areceptor activation attenuates inflammation and injury in diabetic nephropathy
Awad, A. S., Huang, L., Ye, H., Duong, E. T. A., Bolton, W. K., Linden, J. M., & Okusa, M. D. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00310.2005 · Cited by 137
Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose
Amiri, F., Shaw, S., Wang, X., Tang, J., Waller, J. L., Eaton, D. C., & Marrero, M. B. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00311.x · Cited by 134
Nakagawa, T. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00495.2006 · Cited by 134
Neugebauer, S., Baba, T., & Watanabe, T. (2000) · Diabetes · doi:10.2337/diabetes.49.3.500 · Cited by 129
Wong, C. K., Ho, A. M. ‐., Tong, P. C. Y., Yeung, C. Y., Kong, A. P. S., Lun, S. W., Chan, J. C. N., & Lam, C. W. K. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03389.x · Cited by 116
Mechanical Forces in Diabetic Kidney Disease
Gnudi, L., Thomas, S. M., & Viberti, G. C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121362 · Cited by 115
Heilig, C. W., Liu, Y., England, R. L., Freytag, S. O., Gilbert, J. D., Heilig, K. O., Zhu, M., Concepcion, L. A., & Brosius, F. C. (1997) · Diabetes · doi:10.2337/diab.46.6.1030 · Cited by 115
Self-citationBanes, A. K., Shaw, S., Jenkins, J., Redd, H., Amiri, F., Pollock, D. M., & Marrero, M. B. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00163.2003 · Cited by 112
Morcos, M., Borcea, V., Isermann, B., Gehrke, S. G., Ehret, T., Henkels, M., Schiekofer, S., Hofmann, M. A., Amiral, J., Tritschler, H., et al. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00223-6 · Cited by 109
Kakoki, M., Kizer, C. M., Yi, X., Takahashi, N., Kim, H.-S., Bagnell, C. R., Edgell, C.-J. S., Maeda, N., Jennette, J. C., & Smithies, O. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26958 · Cited by 108
Leiter, L. A. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.015 · Cited by 105
Babazono, T., Kapor-Drezgic, J., Dlugosz, J. A., & Whiteside, C. I. (1998) · Diabetes · doi:10.2337/diabetes.47.4.668 · Cited by 96
Usui, H. K., Shikata, K., Sasaki, M., Okada, S., Matsuda, M., Shikata, Y., Ogawa, D., Kido, Y., Nagase, R., Yozai, K., et al. (2007) · Diabetes · doi:10.2337/db06-0359 · Cited by 92
Regulation of Transforming Growth Factor β in Diabetic Nephropathy: Implications for Treatment
Zhu, Y., Usui, H. K., & Sharma, K. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.008 · Cited by 85
Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions.
Yozai, K., Shikata, K., Sasaki, M., Tone, A., Ohga, S., Usui, H., Okada, S., Wada, J., Nagase, R., Ogawa, D., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004111011 · Cited by 85
Agarwal, R. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00289.2005 · Cited by 84
Weigert, C., Brodbeck, K., Brosius, F. C., Huber, M., Lehmann, R., Friess, U., Facchin, S., Aulwurm, S., Häring, H. U., Schleicher, E. D., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.527 · Cited by 69
Self-citationDarbepoetin alfa protects podocytes from apoptosis in vitro and in vivo
Logar, C. M., Brinkkoetter, P. T., Krofft, R. D., Pippin, J. W., & Shankland, S. J. (2007) · Kidney International · doi:10.1038/sj.ki.5002362 · Cited by 66
Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy
Hohenstein, B., Hugo, C. P. M., Hausknecht, B., Boehmer, K., Riess, R. H., & Schmieder, R. E. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm797 · Cited by 62
Schaan, B. D., Lacchini, S., Bertoluci, M. C., Irigoyen, M. C., Machado, U. F., & Schmid, H. (2001) · Hormone and Metabolic Research · doi:10.1055/s-2001-18683 · Cited by 61
Komers, R., Lindsley, J. N., Oyama, T., & Anderson, S. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04534.x · Cited by 58
Minireview: Computer Simulations of Blood Pressure Regulation by the Renin-Angiotensin System
Takahashi, N., Hagaman, J. R., Kim, H., & Smithies, O. (2003) · Endocrinology · doi:10.1210/en.2002-221045 · Cited by 54
Zheng, F., Cornacchia, F., Schulman, I. H., Banerjee, A., Cheng, Q.-L., Potier, M., Plati, A. R., Berho, M. E., Elliot, S. J., Li, J., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2420 · Cited by 50
Roles of Lipid Mediators in Kidney Injury
Hao, C., & Breyer, M. D. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.02.008 · Cited by 46
Allard, J., Buléon, M., Cellier, É., Renaud, I. M., Pécher, C., Praddaude, F., Conti, M., Tack, I., & Girolami, J. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00401.2006 · Cited by 42
Mizuno, M., Sada, T., Kato, M., Fukushima, Y., Terashima, H., & Koike, H. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000245241.79959.d6 · Cited by 40
Levine, D. Z. (2007) · Clinical Science · doi:10.1042/cs20070088 · Cited by 32
Toward a Mouse Model of Diabetic Nephropathy: Is Endothelial Nitric Oxide Synthase the Missing Link?
Quaggin, S. E., & Coffman, T. M. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121396 · Cited by 26
Cited by
Pathologic Classification of Diabetic Nephropathy
Tervaert, T. W. C., Mooyaart, A. L., Amann, K., Cohen, A. H., Cook, H. T., Drachenberg, C. B., Ferrario, F., Fogo, A. B., Haas, M., de Heer, E., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010010 · Cited by 1,690
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Kato, M., & Natarajan, R. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0135-6 · Cited by 600
The cardio-renal-metabolic connection: a review of the evidence
Marassi, M., & Fadini, G. P. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01937-x · Cited by 386
Diabetic nephropathy—emerging epigenetic mechanisms
Kato, M., & Natarajan, R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.116 · Cited by 318
Metadata
- Authors
- Qian, Y., Feldman, E., Pennathur, S., Kretzler, M., & Brosius, F. C.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2008-06-01
- Volume
- 57
- Issue
- 6
- Pages
- 1439-1445
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2113965152
- Cited by
- 325
- References
- 73
- FWCI
- 11.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.